Histological, histochemical and autoradiographic evidence of in vitro neurotoxic effects of the novel antitumor agent, 9-methoxy-N2-methylellipticinium acetate.
9-Methoxy-N2-methylellipticinium acetate (MMEA) exhibits selective cytotoxicity towards glial-derived human brain tumor cell lines comprising the U.S. National Cancer Institute preclinical drug screen. Neurotoxic potential of MMEA has been demonstrated in an in vitro model employing sagittal slices of rat brain. Histochemical staining of rat brain slices for lactate dehydrogenase (LDH) activity revealed decreased staining intensity following incubation with increasing concentrations of MMEA (0.1-100 microM). Cytological evaluation of paraffin sections stained with Cresyl Fast Violet revealed neuronal damage delineated by cytoplasmic vacuolation, and distention and fraying of the plasma membrane. No glial or vascular pathology could be discerned. Autoradiography, following exposure to 14C-MMEA, revealed distinct labelling of the large neurons of the brain stem, neurons in the thalamus and pyramidal neurons of the hippocampus, indicating neuronal uptake of the drug.
Shankar
L
L
Department of Neuropathology, National Institute of Mental Health and Neuroscience, Bangalore, India.
Ravindranath
V
V
Boyd
M R
MR
Vistica
D T
DT
Shankar
S K
SK
D000818:Animals; D000970:Antineoplastic Agents / Q000633:toxicity*; D001345:Autoradiography; D001921:Brain / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D004611:Ellipticines / Q000633:toxicity*; D006651:Histocytochemistry; D066298:In Vitro Techniques; D008297:Male; D009474:Neurons / Q000378:metabolism*; D009498:Neurotoxins / Q000633:toxicity*; D051381:Rats; D017208:Rats, Wistar
D000970:Antineoplastic Agents; D004611:Ellipticines; D009498:Neurotoxins; C091664:9-methoxy-N(2)-methylellipticinium